Wulandari L, Wiriansya EP. COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON NSLCLC PATIENTS WITH DISEASE PROGRESSION AND EGFR-TKI TREATMENT. FMI [Internet]. 2017 Dec. 28 [cited 2024 Nov. 25];53(4):276-82. Available from: https://e-journal.unair.ac.id/FMI/article/view/7161